Sitemap

    1. Media Releases
      1. EMD Serono Receives Health Canada Notice of Compliance for MAVENCLAD™ (cladribine tablets)
      2. Merck KGaA Darmstadt, Germany Announces Recipients of €1 Million Grant for Multiple Sclero
      3. EMD Serono Canada Gives Canadians a Deeper Look into Life with Multiple Sclerosis (MS)
      4. Mavenclad (Cladribine Tablets) Safety Profile in Multiple Sclerosis (MS) Reaffirmed with u
      5. MAVENCLAD™ (cladribine tablets) Receives Positive CADTH Canadian Drug Expert Committee (CD
      6. 2019-04-22 A journey to parenthood: shedding light on fertility
      7. 2019-05-22 MS From the Inside Out Virtual Reality Experience Comes to Montreal for One Day
      8. 2019-12-10 EMD Serono and the pCPA Complete Negotiations for MAVENCLAD
      9. 2020-02-06 Positive Recommendation for MAVENCLAD® (cladribine tablets) from INESSS
      10. 2020-09-29 Canadian Nurse Practitioner, Margaret Prociuk, Receives International Nighting
      11. 2020-10-27 MAVENCLAD® available through public drug plans for most eligible Canadians
      12. 2021-01-06 EMD Serono Appoints Manuel Zafra as New Managing Director for Canada
      13. 2021-01-11 Health Canada Approves BAVENCIO for Maintenance of Advanced Bladder Cancer
      14. 2021-04-06 National Caregiver Day 2021
      15. 2021-04-28 Data Stengthens Evidence for Use of MAVENCLAD During the COVID-19 Pandemic
      16. 2021-04-29 Bavencio Receives Reimbursement Recommendation for Maintenance Treatment of Advanced Bladder Cancer
      17. 2022-04-19 Increase in Cancer Caregivers in Canada
      18. 2022-10-18 Bladder Cancer Canada, EMD Serono and Pfizer Canada announce grant recipients
      19. 2023-06-15 EMD Serono launches Caregivers Concierge: An online resource hub for caregivers
    2. Subscribe to Media Releases
    3. Unsubscribe from Mailing List
    4. Media Contacts